Eli Lilly and Novo Nordisk have agreed to sell their weight loss drugs, Wegovy and Zepbound, through the new TrumpRx ...
Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth ...
WeightWatchers intends to offer Novo Nordisk’s pill version of Wegovy if it makes its US debut next year following potential ...
By Kamal Choudhury and Mariam Sunny (Reuters) -Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to ...
Mangoceuticals' partnership with Lilly and Novo allows the telehealth company to keep selling Zepbound and Wegovy. The telehealth company said Thursday's partnership announcement comes in conjunction ...
Mangoceuticals (MGRX) announces that it has launched MangoRx Direct and PeachesRx Direct, two integrated programs that provide direct access to ...
These branded GLP-1 medications will be made available to both MangoRx and PeachesRx customers via Eli Lilly’s LillyDirect® Self Pay Pharmacy Solutions and Novo Nordisk’s NovoCare Pharmacy. Through ...
WeightWatchers’ CEO said Wednesday the company plans to sell Novo Nordisk’s much-anticipated Wegovy in pill form if it is ...
A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...
One of the biggest gripes around weight loss medications like Wegovy and Zepbound is the high price tag. At $1,000 or more a ...
Eli Lilly is transitioning its employee drug benefit plan from CVS Health to Rightway after a dispute over coverage for its ...
A new clinical trial has found that a once-weekly injection of eloralintide, a new experimental drug, led to weight loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results